Circulating Anti-Müllerian Hormone and Breast Cancer Risk: A Study in Ten Prospective Cohorts. Int J Cancer. 2018; 142:2215-2226

Ge W, Clendenen TV, Afanasyeva Y, et al

Assessment of moderate coffee consumption and risk of epithelial ovarian cancer: a Mendelian randomization study. Int J Epidemiol. 2018; 47:450-459

Ong JS, Hwang LD, Cuellar-Partida G, et al

BRCA2 hypomorphic missense variants confer moderate risks of breast cancer. Cancer Res. 2017; 77:2789-2799

Shimelis H, Mesman RL, Von Nicolai C, et al

Reproductive profiles and risk of breast cancer subtypes: a multi-center case-only study. Breast Cancer Res. 2017; 19(1):119

Brouckaert O, Rudolph A, Laenen A, et al

Smoking and risk of breast cancer in the Generations Study cohort. Breast Cancer Res. 2017;19:118

Jones ME, Schoemaker MJ, Wright LB, Ashworth A, Swerdlow AJ

Gene-environment interactions involving functional variants: Results from the Breast Cancer Association Consortium. Int J Cancer. 2017; 141(9):1830-1840

Barrdahl M, Rudolph A, Hopper JL, et al

The Premenopausal Breast Cancer Collaboration: A pooling project of studies participating in the National Cancer Institute Cohort Consortium. Cancer Epidemiol Biomarkers Prev. 2017; (9):1360-1369

Nichols HB, Schoemaker MJ, Wright LB, et al

Family history and risk of breast cancer: an analysis accounting for family structure. Breast Cancer Res Treat. 2017; 165:193-200

Brewer HR, Jones ME, Schoemaker MJ, Ashworth A, Swerdlow AJ

Genetic modifiers of CHEK2*1100delC-associated breast cancer risk. Genet Med. 2017; 19(5):599-603

Muranen TA, Greco D, Blomqvist C et al

Identification of ten variants associated with risk of estrogen receptor negative breast cancer. Nat Genet. 2017;49(12):1767-1778

Milne RL, Kuchenbaecker KB, Michailidou K, et al


Subscribe to Publications